Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone

Ricardo D. Parrondo; Ricardo de Menezes; Hanna Sledge; Madhavi Nayyar; Kanika Yadav; Leif Bergsagel; Rafael Fonseca; Prashant Kapoor; Francis Buadi; Morie A. Gertz; Angela Dispenzieri; Vivek Roy; Taimur Sher; Moritz Binder; Nadine Abdallah; Saurabh Chhabra; Vincent S. Rajkumar; Wilson I. Gonsalves; Joselle Cook; David Dingli; Yi Lin; Andre Fernandez; Caitlin Flott; Udit Yadav; Rahma M. Warsame; Erin E. Wiedmeier-Nutor; Taxiarchis Kourelis; Nelson Leung; Mustaqeem A. Siddiqui; Shaji Kumar; Asher A. Chanan-Khan; Sikander Ailawadhi

doi:10.3324/haematol.2025.300401

Open access journal of the Ferrata-Storti Foundation, a non-profit organization

Letters to the Editor

Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone

Ricardo D. Parrondo
Ricardo de Menezes
Hanna Sledge
Madhavi Nayyar
Kanika Yadav
Leif Bergsagel
Rafael Fonseca
Prashant Kapoor
Francis Buadi
Morie A. Gertz
Angela Dispenzieri
Vivek Roy
Taimur Sher
Moritz Binder
Nadine Abdallah
Saurabh Chhabra
Vincent S. Rajkumar
Wilson I. Gonsalves
Joselle Cook
David Dingli
Yi Lin
Andre Fernandez
Caitlin Flott
Udit Yadav
Rahma M. Warsame
Erin E. Wiedmeier-Nutor
Taxiarchis Kourelis
Nelson Leung
Mustaqeem A. Siddiqui
Shaji Kumar
Asher A. Chanan-Khan
Sikander Ailawadhi

Division of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL USA

Division of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL USA; Department of Hematology, Hospital Moinhos de Vento, Porto Alegre, Brazil

Division of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL

Division of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL USA

Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ

Division of Hematology, Mayo Clinic, Rochester, MN

Division of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL USA

Division of Hematology, Mayo Clinic, Rochester, MN

Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ

Division of Hematology, Mayo Clinic, Rochester, MN

Division of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL USA

Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ

Division of Hematology, Mayo Clinic, Rochester, MN

Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ

Division of Hematology, Mayo Clinic, Rochester, MN

Division of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL USA

Haematologica Early view Mar 5, 2026 https://doi.org/10.3324/haematol.2025.300401

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor

DOI

https://doi.org/10.3324/haematol.2025.300401

Published

2026-03-05

Published By

Ferrata Storti Foundation, Pavia, Italy

Print ISSN

0390-6078

Online ISSN

1592-8721

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

No Data Yet

Statistics from Altmetric.com

No Data

Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone

Abstract

Figures & Tables

Article Information

Article Usage

Statistics from Altmetric.com

Download Citation

Navigate

For Authors

For Reviewers

For Advertisers

Education

Privacy

More